On the other hand, studies have shown that PVT1 is involved in the induction of gemcitabine resistance by binding to the EZH2 and forming the PVT1/EZH2 complex in pancreatic cancer. This evidence concerns the gene PVT1 and familial pancreatic carcinoma.